GP73, a resident Golgi glycoprotein, is a novel serum marker for hepatocellular carcinoma.
Explore this paper's citation graph
Summary
Higher levels of GP73 can be found in the serum of patients with HCC than of those without, and GP73 was better than AFP for the diagnosis of early HCC.
- Type
- article
- Published
- 2005-12-01
- Cited by
- 380
- References
- 21
- OpenAlex
- https://openalex.org/W2014440272
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:33385934
Keywords
Hepatocellular carcinoma, Cirrhosis, Medicine, Gastroenterology, Internal medicine
References
- A collaborative study for the evaluation of lectin-reactive alpha-fetoproteins in early detection of hepatocellular carcinoma.
- Basic principles of ROC analysis.
- GP73, a novel Golgi-localized protein upregulated by viral infection
- Cycling of Early Golgi Proteins Via the Cell Surface and Endosomes Upon Lumenal pH Disruption
- Annual report to the nation on the status of cancer (1973 through 1998), featuring cancers with recent increasing trends.
- Screening for hepatocellular carcinoma
- Alcohol, tobacco and obesity are synergistic risk factors for hepatocellular carcinoma.
- Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver.
- Comparative proteomic analysis of de‐N‐glycosylated serum from hepatitis B carriers reveals polypeptides that correlate with disease status
- Epidemiology of hepatocellular carcinoma.
- Early detection of hepatocellular carcinoma by real‐time ultrasonography. A prospective study
- Prospective study of screening for hepatocellular carcinoma in Caucasian patients with cirrhosis.
- Hepatocellular carcinoma: diagnosis and treatment.
- A comparison of the molecular clock of hepatitis C virus in the United States and Japan predicts that hepatocellular carcinoma incidence in the United States will increase over the next two decades
- The fucosylation index of alpha‐fetoprotein and its usefulness in the early diagnosis of hepatocellular carcinoma
- Efficacy of a surveillance program for early detection of hepatocellular carcinoma
- Use of targeted glycoproteomics to identify serum glycoproteins that correlate with liver cancer in woodchucks and humans.
- Phases of biomarker development for early detection of cancer.
- Expression of GP73, a resident Golgi membrane protein, in viral and nonviral liver disease
- Selection and interpretation of diagnostic tests and procedures. Principles and applications.
Cited by
- Posttranslational Protein Modifications
- GOLPH2 protein expression as a novel tissue biomarker for prostate cancer: implications for tissue-based diagnostics
- Two-Dimensional N-Glycan Distribution Mapping of Hepatocellular Carcinoma Tissues by MALDI-Imaging Mass Spectrometry
- Impact of Nonsynonymous Single-Nucleotide Variations on Post-Translational Modification Sites in Human Proteins.
- Biomarkers for Hepatocellular Carcinoma
- Application of the Doylestown algorithm for the early detection of hepatocellular carcinoma
- The changing landscape of hepatocellular carcinoma: etiology, genetics, and therapy.
- Diagnose von Tumoren der Leber und Gallenwege
- Liver cancer: from molecular pathogenesis to new therapies: summary of the EASL single topic conference.
- Cancer biomarker discovery and development in gastrointestinal cancers: early detection research network-a collaborative approach.
- Clinical diagnosis and treatment of alpha-fetoprotein-negative small hepatic lesions.
- Proteomics in the diagnosis of hepatocellular carcinoma: focus on high risk hepatitis B and C patients.
- Glycosylation and Liver Cancer
- Decreased survival and hepato-renal pathology in mice with C-terminally truncated GP73 (GOLPH2).
- Insights into glycan biosynthesis in chemically-induced hepatocellular carcinoma in rats: A glycomic analysis.
- Heterogeneity of liver cancer and personalized therapy.
- Multiple lectin assays for detecting glyco-alteration of serum GP73 in liver diseases
- Manganese modified CdTe/CdS quantum dots as an immunoassay biosensor for the detection of Golgi protein-73.
- Development of a Bayesian Joint Logistic Model to Better Study the Association between Haplotypes and Disease
- GP73 expression and its significance in the diagnosis of hepatocellular carcinoma: a review.
Related papers
- Clinicopathologic features and risk factors for hepatocellular carcinoma: results from a single center in southern Turkey.
- Pathology of hepatocellular carcinoma
- Spontaneous rupture of hepatocellular carcinoma.
- Application of Diffusion Weighted Imaging in Liver Cirrhosis and Hepatocellular Carcinoma at 3.0 T Magnetic Resonance
- Expression of TRA1 mRNA in hepatocellular carcinoma and liver cirrhosis tissue
- Reply to: "Inappropriate use of FIB-4 index for cirrhosis detection in hepatocellular carcinoma patients".
- Risk factors of hepatocellular carcinoma in Germany: hepatitis B or liver cirrhosis?